Aberrant pattern of the cytokeratin 7/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations.
about
Serrated pathway adenocarcinomas: molecular and immunohistochemical insights into their recognition.Activation of pro-oncogenic pathways in colorectal hyperplastic polyps.Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcomeCytokeratin7 expression in gastric and colorectal adenocarcinoma: Correlation with prognostic factorsComprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer.Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series.Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer.A clinicopathological and molecular analysis of 200 traditional serrated adenomas.A Critical Evaluation of the PAXgene Tissue Fixation System: Morphology, Immunohistochemistry, Molecular Biology, and Proteomics.Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review).Novel mouse model recapitulates genome and transcriptome alterations in human colorectal carcinomas.Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles.Identification of proteins associated with paclitaxel resistance of epithelial ovarian cancer using iTRAQ-based proteomics.
P2860
Q34613174-7CFA058B-A2ED-4FA7-B030-930589D92F5FQ35037550-900EC269-2A6E-4485-B2EE-804CDB7A6D89Q36232027-1B3A712D-1002-4921-BEC2-3964EECE9B4CQ36290905-61C3C015-58C9-4291-8EC1-C2DF072EADAAQ38773906-B725659A-72E3-478D-A518-BBC591B05E69Q41942838-8054CC04-B058-4EED-95E7-3E42FEE8D828Q47150476-A9B0A756-1C1D-4C56-A7EE-089B18C4903FQ51113698-E6449EB2-BD36-4424-A756-7665C60A95ECQ51648276-C69B1DF3-3788-4433-A1A9-7D39C8B075D4Q51732351-808AEF24-3927-4A95-80A2-66032B10EFF2Q52975664-A9A5FD0A-CCD0-44ED-89C4-A105A9368807Q53413457-47A74B47-0DF7-4171-A3A6-CA1AEEB1CE7DQ55306983-4F7A216D-8035-4C42-A0C5-71365B8878E6
P2860
Aberrant pattern of the cytokeratin 7/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Aberrant pattern of the cytoke ...... arcinomas with BRAF mutations.
@en
Aberrant pattern of the cytoke ...... arcinomas with BRAF mutations.
@nl
type
label
Aberrant pattern of the cytoke ...... arcinomas with BRAF mutations.
@en
Aberrant pattern of the cytoke ...... arcinomas with BRAF mutations.
@nl
prefLabel
Aberrant pattern of the cytoke ...... arcinomas with BRAF mutations.
@en
Aberrant pattern of the cytoke ...... arcinomas with BRAF mutations.
@nl
P1476
Aberrant pattern of the cytoke ...... carcinomas with BRAF mutations
@en
P2093
P304
P356
10.1016/J.PRP.2012.01.003
P50
P577
2012-02-21T00:00:00Z